Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Clinical trial NCT02174549 · RECRUITING
Trial details
- NCT number
- NCT02174549
- Sponsor
- Teclison Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2028-03-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.